This mutation demonstrated statistically significant association with pancreatic cancer risk in unadjusted odds ratio (OR: 3.74, 95% CI: 1.1–13.2; P = 0.041); however when adjusted for confounding factors, it was marginally significant because of lower control samples.
← all excerpts
Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer.
1
—
—